Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comparison of hepatic arterial infusion chemotherapyversussorafenib monotherapy in patients with advanced hepatocellular carcinoma

(2015) Tomokazu Kawaoka et al.   Journal of Digestive Diseases

2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma

(2015) et al.   KOREAN JOURNAL OF RADIOLOGY

Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma

(2015) Myeong Jun Song   WORLD JOURNAL OF GASTROENTEROLOGY

Current Status of Hepatic Arterial Infusion Chemotherapy

(2015) Shuntaro Obi et al.   Liver Cancer

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis

(2014) Do Seon Song et al.   JOURNAL OF GASTROENTEROLOGY

Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study

(2013) Jordi Bruix et al.   EUROPEAN JOURNAL OF CANCER

Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis

(2013) Soung Won Jeong et al.   Gut and Liver

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study

(2011) YASUNARI HIRAMINE et al.   Experimental and Therapeutic Medicine

Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma

(2010) Yu-Yun SHAO et al.   Asia-Pacific Journal of Clinical Oncology

Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

(2010) Alejandro Forner et al.   SEMINARS IN LIVER DISEASE

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma

(2009) Hyun Young Woo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-α for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis

(2009) Jong Ryul Eun et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE